Showing results (1131-1140 of 6,956) with videos related to
Sort By:
Pageof 696
Journal of Clinical Pharmacology|May 16, 2019
Physiologically Based Pharmacokinetic Modeling to Evaluate Formulation Factors Influencing Bioequivalence of Metoprolol Extended-Release ProductsSumit Basu, Haitao Yang, Lanyan Fang, et al.Journal of Clinical Pharmacology|May 21, 2019
Quantitative Comparison of the Efficacies of 5 First-Line Drugs for Primary Restless Leg SyndromeNingyuan Zhang, Yunfei Li, Yinghua Lv, et al.Journal of Clinical Pharmacology|May 11, 2019
Pharmacokinetics of Lapatinib, a Nonrenally Cleared Drug, in Patients With End-Stage Renal Disease on Maintenance HemodialysisSudhakar M Pai, Philip Chaikin, Jolene Kay BergJournal of Clinical Pharmacology|August 1, 1988
Efficacy of esmolol in the treatment and transfer of patients with supraventricular tachyarrhythmias to alternate oral antiarrhythmic agentsG Das, V Tschida, R Gray, et al.Journal of Clinical Pharmacology|August 1, 1988
Effect of cetamolol on epinephrine-induced hypokalemiaM A Klausner, C Irwin, J F Mullane, et al.Journal of Clinical Pharmacology|August 1, 1978
Effect of abdominal radiation therapy on drug absorption in humansG H Sokol, D J Greenblatt, B L Lloyd, et al.Journal of Clinical Pharmacology|September 20, 2017
Model-Based Assessment Using Conventional Bioequivalence Limits to Ensure Safety and Efficacy of Rivaroxaban in Patients Undergoing Hip or Knee ReplacementMario González-Sales, Lanyan Fang, Myong-Jin Kim, et al.Journal of Clinical Pharmacology|November 27, 2018
Abuse Potential of Samidorphan: A Phase I, Oxycodone-, Pentazocine-, Naltrexone-, and Placebo-Controlled StudySanjeev Pathak, Bradley Vince, Debra Kelsh, et al.Journal of Clinical Pharmacology|March 27, 2018
MAO-B and COMT Genetic Variations Associated With Levodopa Treatment Response in Patients With Parkinson's DiseaseTiago Furtado Sampaio, Erinaldo Ubirajara Damasceno Dos Santos, Gessica Dayane Cordeiro de Lima, et al.Journal of Clinical Pharmacology|November 15, 2017
Brompheniramine and Chlorpheniramine Pharmacokinetics Following Single-Dose Oral Administration in Children Aged 2 to 17 YearsSudam Pathirana, Shyamalie Jayawardena, Suzanne Meeves, et al.Pageof 696